SCHEMBL6581453

SCHEMBL6581453

Cc1ccc2cc(OCc3c(C)ccc([N+](=O)[O-])c3C)ccc2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.40
MAPT P10636 5/20 0.38
SMN1; SMN2 Q16637 4/20 0.37
CYP1A2 P05177 2/20 0.37
TP53 P04637 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
HIF1A Q16665 1/20 0.37
LMNA P02545 2/20 0.37
GAA P10253 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MAOB P27338 1/20 0.37
HTR1A P08908 1/20 0.35
HTR1D P28221 1/20 0.35
HTR1B P28222 1/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
S1PR4 O95977 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6581385 0.82 TP53 (0.42) ALDH1A1MAPTSMN1; SMN2CYP1A2TP53
SCHEMBL6580688 0.81 ALDH1A1 (0.36) ALDH1A1MAPTSMN1; SMN2CYP1A2TP53
SCHEMBL6578371 0.81 ALDH1A1 (0.44) ALDH1A1MAPTSMN1; SMN2CYP1A2CYP2D6
SCHEMBL6576127 0.80 S1PR4 (0.42) ALDH1A1MAPTSMN1; SMN2CYP1A2TP53
SCHEMBL6580686 0.80 S1PR4 (0.44) ALDH1A1MAPTSMN1; SMN2CYP1A2TP53
SCHEMBL6581464 0.80 KDM4E (0.44) ALDH1A1MAPTCYP1A2LMNAL3MBTL1
SCHEMBL6578500 0.79 ALDH1A1 (0.43) ALDH1A1MAPTSMN1; SMN2CYP1A2CYP2D6
SCHEMBL6576231 0.78 MAPT (0.40) ALDH1A1MAPTSMN1; SMN2CYP1A2TP53
SCHEMBL6581287 0.77 MAPT (0.42) ALDH1A1MAPTSMN1; SMN2CYP1A2CYP2D6
SCHEMBL6580761 0.77 MAPT (0.42) ALDH1A1MAPTSMN1; SMN2CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0867432-B1 Fused N-heterocyclic compounds substituted with benzyloxy, process for their preparation and their use as bradykinin receptor antagonists AVENTIS PHARMA GMBH (DE) 2004-06-09 EP disclosed
EP-0867432-A2 Fused N-heterocyclic compounds substituted with benzyloxy, process for their preparation and their use as bradykinin receptor antagonists HOECHST AKTIENGESELLSCHAFT (DE) 1998-09-30 EP disclosed